A
$ Value
$16K
Shares
5,930
Price
$3
Filed
Mar 17
Insider
Name
Otero Jose Manuel
Title
Chief Operating Officer
CIK
0002024096
Roles
Officer
Transaction Details
Transaction Date
2026-03-13
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
131,390
Footnotes
The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d). | Includes 104,216 restricted stock units.
Filing Info
Otero Jose Manuel's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-13 | LXEO | A | $16K |
| 2026-02-18 | LXEO | ▼ | $19K |
| 2026-02-04 | LXEO | A | $0 |
| 2026-02-04 | LXEO | A | $0 |
| 2025-11-18 | LXEO | ▼ | $7K |
| 2025-10-17 | LXEO | ▼ | $19K |
| 2025-10-17 | LXEO | ▼ | $229 |
| 2025-10-15 | LXEO | A | $0 |
| 2025-08-18 | LXEO | ▼ | $13K |
| 2025-08-18 | LXEO | ▼ | $7K |
Other Insiders at LXEO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Townsend Richard Nolan
Chief Executive Officer
|
— | $378K | 2026-04-06 |
|
Otero Jose Manuel
Chief Operating Officer
|
— | $26K | 2026-02-18 |
|
Tamayo Louis Edward
Chief Financial Officer
|
— | — | 2026-02-04 |
|
Bhalla Narinder Pal
Chief Medical Officer
|
— | — | 2026-02-13 |